Erik Ingelsson
Fortune : 578 145 $ au 31/05/2026
Fortune : 578 145 $ au 31/05/2026
Erik Ingelsson currently works at Wave Life Sciences Ltd., as Chief Scientific Officer from 2024.
Dr. Ingelsson also formerly worked at GSK Plc, as Senior Vice President & Head-Target Discovery and Stanford University, as Professor-Medicine from 2015 to 2019.
Dr. Ingelsson received his doctorate degree from the University of Uppsala.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/04/2026 | 87 864 ( 0,05% ) | 578 145 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Directeur Technique/Scientifique/R&D | 09/05/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2019 |
| GSK PLC | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national